Cubist’s products include Cubicin, which treats infections. (Bloomberg News/File)
Cubist completes deal for rival drug maker
December 18, 2011
Text size – +
Cubist Pharmaceuticals Inc. said Monday that it has completed its acquisition of fellow drug maker Adolor Corp. for about $221 million.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
Click to continue reading this article or to log in to BostonGlobe.com.